Source:http://linkedlifedata.com/resource/pubmed/id/20933244
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-16
|
pubmed:abstractText |
Cardiogenic shock still carries a very high mortality. We adopted veno-arterial extracorporeal membrane oxygenation using the Levitronix centrifugal pump (Levitronix LLC, Waltham, Massachusetts) as a first-line treatment of cardiogenic shock in a "bridge to decision" strategy. This article provides our experience of this clinical approach.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1097-685X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1416-21
|
pubmed:meshHeading |
pubmed-meshheading:20933244-Adolescent,
pubmed-meshheading:20933244-Adult,
pubmed-meshheading:20933244-Aged,
pubmed-meshheading:20933244-Extracorporeal Membrane Oxygenation,
pubmed-meshheading:20933244-Female,
pubmed-meshheading:20933244-Heart-Assist Devices,
pubmed-meshheading:20933244-Humans,
pubmed-meshheading:20933244-Infant,
pubmed-meshheading:20933244-Male,
pubmed-meshheading:20933244-Middle Aged,
pubmed-meshheading:20933244-Retrospective Studies,
pubmed-meshheading:20933244-Shock, Cardiogenic,
pubmed-meshheading:20933244-Survival Rate,
pubmed-meshheading:20933244-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock.
|
pubmed:affiliation |
A De Gasperis Cardiology & Cardiac Surgery Department, Niguarda Ca' Granda Hospital, Milan, Italy. claudio.russo@ospedaleniguarda.it
|
pubmed:publicationType |
Journal Article
|